2023 - Research.com Immunology in United Kingdom Leader Award
His primary areas of investigation include Immunology, T cell, Indoleamine 2,3-dioxygenase, Cell biology and Immune tolerance. His work in the fields of Immunology, such as Immune system, Antigen, Immunotherapy and Adoptive cell transfer, overlaps with other areas such as Population. His studies deal with areas such as In vitro, CD8 and Major histocompatibility complex as well as T cell.
His study in Indoleamine 2,3-dioxygenase is interdisciplinary in nature, drawing from both Acquired immune system, Cancer research, Dendritic cell, Immunosuppression and Dioxygenase. His Cell biology research includes elements of CD28, Biochemistry and Macrophage. His research in Immune tolerance intersects with topics in Cellular immunity and Sirolimus.
His primary areas of study are Immunology, T cell, Immune system, Indoleamine 2,3-dioxygenase and Cytotoxic T cell. His study on Immunology is mostly dedicated to connecting different topics, such as Cell biology. His T cell study integrates concerns from other disciplines, such as Tryptophan, T lymphocyte, Signal transduction and Transplantation.
His Indoleamine 2,3-dioxygenase research incorporates themes from Dendritic cell, CD19, Graft-versus-host disease and Immunosuppression. His study focuses on the intersection of Cytotoxic T cell and fields such as Molecular biology with connections in the field of Gene, Genetically modified mouse, T-cell receptor, Transgene and Clonal deletion. His research investigates the connection between Immune tolerance and topics such as Immunotherapy that intersect with problems in Cancer research.
Andrew L. Mellor mainly investigates Immunology, Immune system, Cancer research, T cell and Autoimmunity. His Immunology study frequently draws connections between adjacent fields such as Indoleamine 2,3-dioxygenase. His Immune system research is multidisciplinary, incorporating elements of Receptor, Pharmacology, Cell growth and Cell biology.
His studies in Cancer research integrate themes in fields like Immune checkpoint, Adoptive immunotherapy, Melphalan, Tumor microenvironment and Regulatory T cell. The concepts of his T cell study are interwoven with issues in Acquired immune system, Cytokine, Function, Cell therapy and Myelin oligodendrocyte glycoprotein. His Autoimmunity research integrates issues from Arthritis, Stimulator of interferon genes, DNA, Systemic lupus erythematosus and Interferon type I.
Andrew L. Mellor spends much of his time researching Immunology, Immune system, Immunotherapy, T cell and Cell biology. His Immunology study combines topics from a wide range of disciplines, such as Carcinogenesis and Radiation therapy. His work carried out in the field of Immune system brings together such families of science as Receptor, Cancer research and Indoleamine 2,3-dioxygenase.
His Indoleamine 2,3-dioxygenase research is multidisciplinary, relying on both Tensin and PTEN. His T cell research focuses on subjects like Acquired immune system, which are linked to Endocrinology and Internal medicine. His biological study spans a wide range of topics, including Interleukin 3, Cellular differentiation, Inflammation, Proinflammatory cytokine and Apoptosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prevention of allogeneic fetal rejection by tryptophan catabolism
David H. Munn;Min Zhou;John T. Attwood;Igor Bondarev.
IDO expression by dendritic cells: tolerance and tryptophan catabolism.
Andrew L. Mellor;David H. Munn.
Nature Reviews Immunology (2004)
INHIBITION OF T CELL PROLIFERATION BY MACROPHAGE TRYPTOPHAN CATABOLISM
David H. Munn;Ebrahim Shafizadeh;John T. Attwood;Igor Bondarev.
Journal of Experimental Medicine (1999)
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Brian J. Miller;Peter Buckley;Wesley Seabolt;Andrew Mellor.
Biological Psychiatry (2011)
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
David H. Munn;Madhav D. Sharma;Jeffrey R. Lee;Kanchan G. Jhaver.
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.
David H. Munn;Madhav D. Sharma;Babak Baban;Heather P. Harding.
Indoleamine 2,3-dioxygenase and tumor-induced tolerance.
David H. Munn;Andrew L. Mellor.
Journal of Clinical Investigation (2007)
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
David H. Munn;Madhav D. Sharma;Deyan Hou;Babak Baban.
Journal of Clinical Investigation (2004)
cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines
Christer Betsholtz;Ann Johnsson;Carl-Henrik Heldin;Bengt Westermark.
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase
Madhav D. Sharma;Babak Baban;Phillip Chandler;De Yan Hou.
Journal of Clinical Investigation (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: